1)Nishi D, et al:Prevalence of mental disorders and mental health service use in Japan. Psychiatry Clin Neurosci 73:458-465, 2019 PMID 31141260
2)Donabedian A:Evaluating the quality of medical care. Milbank Mem Fund Q 44:Suppl 166-206, 1996 PMID 5338568
3)Petrosyan Y, et al:Quality indicators for care of depression in primary care settings;A systematic review. Syst Rev 6:s13643-017-0530-7, 2017 PMID 28673356
4)Hashimoto N, et al:Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder;Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education(EGUIDE)psychiatric treatment project. Asian J Psychiatr 63:102744, 2021 PMID 34325252
5)Yamada H, et al:A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders;The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment(EGUIDE)project. BJPsych Open 8:e83, 2022 PMID 35446248
6)Qaseem A, et al;Clinical Guidelines Committee of the American College of Physicians:Quality indicators for major depressive disorder in adults; A review of performance measures by the American College of Physicians. Ann Intern Med 177:507-513, 2024 PMID 38437692
7)Qaseem A, et al;Clinical Guidelines Committee of the American College of Physicians:Nonpharmacologic and pharmacologic treatments of adults in the acute phase of Major Depressive Disorder;A living clinical guideline from the American College of Physicians. Ann Intern Med 176:239-252, 2023 PMID 36689752
8)Petrosyan Y, et al:Quality indicators for care of depression in primary care settings;A systematic review. Syst Rev 6:126, 2017 PMID 28673356